Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
08/10/1994 | EP0424484B1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection |
08/10/1994 | CN1090582A New erythromycin derivatives, their preparation process and their use as medicaments |
08/10/1994 | CN1090581A New derivatives of erythromycin, their preparation process, their use as medicaments |
08/10/1994 | CN1025616C Chemical Process |
08/10/1994 | CN1025608C New fluoro-naphthacenediones, their glycosilatede derivatives and their manufacture procedures |
08/10/1994 | CA2115021A1 Derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid |
08/09/1994 | US5336770 Reacting guanosine and 2-oxa-1,4-butanediol diacetate in the presence of an acid catalyst and acid anhydride followed by ester hydrolysis to produce acyclovir |
08/09/1994 | US5336764 Reverse transcriptase inhibitor; HIV viricides; AIDS therapy |
08/09/1994 | US5336758 AIDS vaccines |
08/09/1994 | US5336756 Dissolving in propanol allowing to crystallize |
08/09/1994 | US5336674 2-phenanthridinyl carbaphenem antibacterial agent |
08/09/1994 | US5336673 3-substituted cephem compounds |
08/09/1994 | US5336500 For disinfection of hard surfaces |
08/09/1994 | CA1331381C Antibacterial agents - ii |
08/09/1994 | CA1331345C Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth |
08/04/1994 | WO1994017123A1 Sulfate of n-acetylneuraminic acid homopolymer, process for producing the same, anti-hiv drug containing said sulfate, method of treating aids with said sulfate, use of said sulfate for treating aids, and use of said sulfate for producing the drug |
08/04/1994 | WO1994017104A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
08/04/1994 | WO1994017094A1 Oligodeoxynucleotides containing 5-alkyl-, 5-(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds |
08/04/1994 | WO1994017093A1 Oligonucleotide alkylphosphonates and alkylphosphonothioates |
08/04/1994 | WO1994017091A2 Foldback triplex-forming oligonucleotides |
08/04/1994 | WO1994017085A1 Desalaninebenanomicin a derivative and production thereof |
08/04/1994 | WO1994017074A1 Process for the manufacture of a tricyclic compound |
08/04/1994 | WO1994017066A1 2-phenanthridinyl carbapenem antibacterial agents |
08/04/1994 | WO1994017065A1 2-phenanthridinyl carbapenem antibacterial agents |
08/04/1994 | WO1994017055A1 Antiviral naphthoquinone compounds, compositions and uses thereof |
08/04/1994 | WO1994017034A1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation |
08/04/1994 | WO1994016737A1 Compositions and methods for delivery of genetic material |
08/04/1994 | WO1994016736A1 Localization of therapeutic agents |
08/04/1994 | WO1994016730A1 Human monoclonal antibodies to cytomegalovirus |
08/04/1994 | WO1994016724A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
08/04/1994 | WO1994016715A1 Selective cell proliferation |
08/04/1994 | WO1994016700A1 Method and composition employing (2r,4s) itraconazole |
08/04/1994 | WO1994016696A1 Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
08/04/1994 | WO1994016681A1 Recombinant living subunit vaccine composition and process for its preparation |
08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
08/04/1994 | WO1994005700A3 Methods and reagents to detect and characterize norwalk and related viruses |
08/04/1994 | CA2154902A1 Recombinant living subunit vaccine composition and process for its preparation |
08/04/1994 | CA2154787A1 Selective cell proliferation |
08/04/1994 | CA2154777A1 Method and composition employing (2r,4s) itraconazole |
08/04/1994 | CA2154578A1 Oligonucleotide alkylphosphonates and alkylphosphonothioates |
08/04/1994 | CA2154487A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
08/04/1994 | CA2154474A1 Oligodeoxynucleotides containing 5-alkyl, 5-(1-alkenyl)-and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds |
08/04/1994 | CA2154363A1 Localization of therapeutic agents |
08/04/1994 | CA2154358A1 Integrated oligonucleotides |
08/04/1994 | CA2154346A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
08/04/1994 | CA2154276A1 2-phenanthridinyl carbapenem antibacterial agents |
08/04/1994 | CA2154275A1 2-phenanthridinyl carbapenem antibacterial agents |
08/04/1994 | CA2153790A1 Human monoclonal antibodies to cytomegalovirus |
08/04/1994 | CA2114777A1 Cytotoxic compounds |
08/03/1994 | EP0608809A1 Antiviral tetrahydropyrans |
08/03/1994 | EP0608353A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES. |
08/03/1994 | EP0608261A1 Immunoreactive hepatitis c virus polypeptide compositions |
08/03/1994 | EP0608212A1 Method of treating viral infection |
08/03/1994 | CN1090326A Mammalian receptors for interleukin-10 (IL-10) |
08/03/1994 | CN1090285A Quinolonecarboxylic acids |
08/03/1994 | CN1090283A Carbapenem derivatives and processes for preparing the same |
08/03/1994 | CN1090279A Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
08/03/1994 | CN1090277A Benzoxazinones as inhibitors of HIV reverse transcriptase |
08/03/1994 | CN1090267A Novel 7-(substituted)-8-(substituted)-9-(substituted Amino)-6-demethyi-6-deoxytetracyclines |
08/02/1994 | US5334717 Inhibit lentiviruses |
08/02/1994 | US5334711 Synthetic catalytic oligonucleotide structures |
08/02/1994 | US5334612 Solid, semisolid, solution, suspension or emulsion dosage unit |
08/02/1994 | US5334589 Bactericides for treating infections; stability, side-effect reduction |
08/02/1994 | US5334587 For adverse reactions from cancer chemotherapy, infections, cerebral dysfunction or fungal infection |
08/02/1994 | US5334394 A core particle with a surface coatings consisting of maltose, cellobiose, trehalose, isomaltose, nystose, maltotriose and nitrocellulose, bonding with immobilized virus cells; aids vaccines |
08/02/1994 | US5334375 Antibacterial antiplaque oral composition |
08/02/1994 | CA1331138C Use of reverse transcriptase inhibitor for treatment of human breast carcinoma |
08/02/1994 | CA1331134C Purification of pertussis toxins |
08/02/1994 | CA1331132C Method of treatment for non-specific inflammation |
07/30/1994 | CA2114355A1 Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
07/27/1994 | EP0607825A1 6-H-4-OXO-3-quinoline-carboxylic acids and their analogues as antibacterial agents |
07/27/1994 | EP0607776A2 Use of leflunomid for the inhibition of tumor necrosis factor alpha |
07/27/1994 | EP0607775A2 Use of leflunomid for the inhibition of interleukin 1 beta |
07/27/1994 | EP0607425A1 Epstein-barr virus peptides and antibodies against these peptides |
07/27/1994 | EP0607408A1 Transvascular and intracellular delivery of lipidized proteins |
07/27/1994 | EP0607368A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
07/27/1994 | EP0607334A1 Cyclic ureas and analogues useful as retroviral protease inhibitiors. |
07/27/1994 | EP0607329A1 New derivatives of fluoro-quinoline carboxylic-3 acid and preparation thereof |
07/27/1994 | EP0607252A1 Method of treating hiv infection |
07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
07/27/1994 | EP0607193A1 Triazole antifungal agents |
07/27/1994 | EP0603303A4 Antimicrobial compositions containing propylene carbonate and/or ethylene carbonate as the carrier solvent. |
07/27/1994 | EP0506769B1 Pharmaceutical composition for treating or preventing retroviral infections |
07/27/1994 | CN1089948A Triazolylthiomethylthio cephalosporin hydrochloride, its crystalline hydrate and the production of the same |
07/27/1994 | CN1089839A Pharmaceutical composition |
07/26/1994 | US5332814 Process for the preparation of carbacyclic nucleosides, and intermediates |
07/26/1994 | US5332749 Quinolones, process for their preparation and pharmaceutical compositions containing same |
07/26/1994 | CA2111549A1 Antiviral tetrahydropyrans |
07/26/1994 | CA1330990C Antiviral compounds |
07/26/1994 | CA1330944C Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
07/21/1994 | WO1994016096A2 Method to predict active growth of bacteria adhered to a surface |
07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
07/21/1994 | WO1994016081A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv |
07/21/1994 | WO1994016073A2 Methods and reagents for inhibiting furin endoprotease |
07/21/1994 | WO1994015938A1 Novel quinolone derivatives and processes for preparing the same |
07/21/1994 | WO1994015933A1 Novel pyridone carboxylic acid derivatives |
07/21/1994 | WO1994015909A1 Amino acids and peptides having modified terminals |
07/21/1994 | WO1994015900A1 Anti-androgenic cyclo and bicyclo alkenes |
07/21/1994 | WO1994015638A1 Antibodies directed against binding-associated epitopes |
07/21/1994 | WO1994015636A1 Vaccine preparations |